Finance & Investment (Pharma & Healthcare)


Finance and Investment (Pharma and Healthcare) Market Research Reports Analysis and Trends

The Finance and Investment in Pharma and Healthcare industry gives information on budgets, supplier selection criteria, business challenges and investment opportunities of leading purchase decision makers. The report also gives information on future growth of buyers and suppliers, e-procurement, opinions and strategies of business decision makers and competitors, business priorities, company type and sizes respectively, market analysis of the pharmaceutical company.

The Key features of Finance and Investment in Pharma and Healthcare industry reports are:  

  • Profits growth and future developments in business structure of pharmaceutical industry.
  • Merger and acquisition activity of Pharma companies.
  • Capital expenditure and change in staff recruitment activity in Pharma companies.
  • Key regions of growth within the company.
  • Key industry threats and opportunities of pharmaceutical industry.
  • Key supplier actions and e-procurement.
  • Annual procurement budgets and change in procurement expenditure.
  • Change in supplier selection and procurement objectives of the company.
  • Costs involved in various pharmaceutical company products.
Title Published Pages Price Buy This Publication Now
Global Cervical Cancer Partnering 2010 to 2016 Global Cervical Cancer Partnering 2010 to 2016 May 2 2016 150 $1,495.00
Hospira Partnering Deals and Alliances 2010 to 2016 Hospira Partnering Deals and Alliances 2010 to 2016 May 2 2016 100 $1,495.00
Global Respiratory Partnering 2010-2016: Deal trends, players and financials Global Respiratory Partnering 2010-2016: Deal trends, players and financials May 2 2016 800 $2,995.00
Global Smoking Cessation Partnering 2010 to 2016 Global Smoking Cessation Partnering 2010 to 2016 May 2 2016 100 $1,495.00
Global Epilepsy Partnering 2010 to 2016 Global Epilepsy Partnering 2010 to 2016 May 2 2016 150 $1,495.00
Regeneron Pharmaceuticals Partnering Deals and Alliances 2010 to 2016 Regeneron Pharmaceuticals Partnering Deals and Alliances 2010 to 2016 May 2 2016 100 $1,495.00
Boehringer Ingelheim Partnering Deals and Alliances 2010 to 2016 Boehringer Ingelheim Partnering Deals and Alliances 2010 to 2016 May 2 2016 100 $1,495.00
Global Musculoskeletal Symptoms Partnering 2010-2016 Global Musculoskeletal Symptoms Partnering 2010-2016 May 2 2016 100 $1,495.00
Global Herpes simplex Partnering 2010 to 2016 Global Herpes simplex Partnering 2010 to 2016 May 2 2016 150 $1,495.00
Global Genetic disorders Partnering 2010-2016: Deal trends, players and financials Global Genetic disorders Partnering 2010-2016: Deal trends, players and financials May 2 2016 500 $2,995.00
Global Arthritis Partnering 2010 to 2016 Global Arthritis Partnering 2010 to 2016 May 2 2016 200 $1,495.00
Global Acute and Chronic Myelogenous Leukemia Partnering 2010 to 2016 Global Acute and Chronic Myelogenous Leukemia Partnering 2010 to 2016 May 2 2016 150 $1,495.00
Monsanto Partnering Deals and Alliances 2010 to 2016 Monsanto Partnering Deals and Alliances 2010 to 2016 May 2 2016 100 $1,495.00
Amgen Partnering Deals and Alliances 2010 to 2016 Amgen Partnering Deals and Alliances 2010 to 2016 May 2 2016 100 $1,495.00
Global Discovery Stage Partnering Terms and Agreements in Pharma and Biotech 2010- 2016 Global Discovery Stage Partnering Terms and Agreements in Pharma and Biotech 2010- 2016 May 2 2016 1000 $2,995.00
Global Cystic Fibrosis Partnering 2010 to 2016 Global Cystic Fibrosis Partnering 2010 to 2016 May 2 2016 100 $1,495.00
Targacept Partnering Deals and Alliances 2010 to 2016 Targacept Partnering Deals and Alliances 2010 to 2016 May 2 2016 100 $1,495.00
Eli Lilly Partnering Deals and Alliances 2010 to 2016 Eli Lilly Partnering Deals and Alliances 2010 to 2016 May 2 2016 100 $1,495.00
Global Brain Cancer Partnering 2010 to 2016 Global Brain Cancer Partnering 2010 to 2016 May 2 2016 150 $1,495.00
GlaxoSmithKline Partnering Deals and Alliances 2010 to 2016 GlaxoSmithKline Partnering Deals and Alliances 2010 to 2016 May 2 2016 100 $1,495.00
Global Psychiatry Partnering 2010-2016: Deal trends, players and financials Global Psychiatry Partnering 2010-2016: Deal trends, players and financials May 2 2016 700 $2,995.00
Global Obesity Partnering 2010 to 2016 Global Obesity Partnering 2010 to 2016 May 2 2016 100 $1,495.00
Global Motor Neurone Disease Partnering 2010 to 2016 Global Motor Neurone Disease Partnering 2010 to 2016 May 2 2016 150 $1,495.00
Questcor Pharmaceuticals Partnering Deals and Alliances 2010 to 2016 Questcor Pharmaceuticals Partnering Deals and Alliances 2010 to 2016 May 2 2016 100 $1,495.00
Biomarin Pharmaceuticals Partnering Deals and Alliances 2010 to 2016 Biomarin Pharmaceuticals Partnering Deals and Alliances 2010 to 2016 May 2 2016 100 $1,495.00
Global Lysosomal Storage Disease Partnering 2010-2016 Global Lysosomal Storage Disease Partnering 2010-2016 May 2 2016 100 $1,495.00
Global Sepsis Partnering 2010 to 2016 Global Sepsis Partnering 2010 to 2016 May 2 2016 150 $1,495.00
Global Dermatology Partnering 2010-2016: Deal trends, players and financials Global Dermatology Partnering 2010-2016: Deal trends, players and financials May 2 2016 500 $2,995.00
Global Liver Disease Partnering 2010 to 2016 Global Liver Disease Partnering 2010 to 2016 May 2 2016 100 $1,495.00
Global Solid Tumor Partnering 2010 to 2016 Global Solid Tumor Partnering 2010 to 2016 May 2 2016 150 $1,495.00

Pages

Shopping cart

0 Items $0.00
Not able to find what you are looking for?
Call Us
WHY CHOOSE MARKET RESEARCH REPORTS?
1
Trusted By Leaders
2
Shop With Confidence
3
Customer Centric
4
Personalized Solutions
5
Secure Checkout

User login

Clients Who Trust Us

Orange, Google, Microsoft, Barclays, CassidianIntel, TPG, Elit Net, Cross Business Producers, AcmavolpakP&G, Cisco, Gemalto, General Insurance Corporation of India, Aviva, Cognizant, InoxWindB. Braun, Cobham, fiserv, Harris, Wipro, AonAl Meera, Nomura Research Institute, Tata Consultancy Services, Amara Raja, Hiranandani EnergyMunich Re, Lotte Chemical, National Post, First Data